Singular Genomics Systems is a life science technology company that is utilizing next-generation sequencing (NGS) and multiomics technologies to empower researchers and clinicians. Co. has developed a proprietary NGS technology, which it refers to as its Sequencing Engine. Co.'s primary product, the G4, targets the NGS market and is comprised of an instrument and associated menu of consumable kits. Co.'s second product in development, the PX, combines single-cell analysis, spatial analysis, genomics and proteomics in one integrated instrument to provide a versatile multiomics solution. The OMIC YTD return is shown above.
The YTD Return on the OMIC YTD return page and across the coverage universe of our site,
is a measure of the total return for a given investment year-to-date for the current calendar year
(up to the end of prior trading session). Arguably, choosing the current calendar year for a measurement
period is on the one hand completely arbitrary, but on the other hand a year-to-date look can be extremely
useful in the context of our country's tax system which taxes gains and income on a calendar year basis.
Thus, researching Year-To-Date Returns is good practice for investors — whether OMIC YTD return or other benchmarks/peers
— and when doing so it is also important to factor in dividends, because a financial instrument's YTD return is
more than just the change in price if that instrument pays a dividend or coupon. Our website aims to empower investors
by performing the OMIC YTD return calculation (with any dividends reinvested as applicable), and to provide a
coverage universe of many stocks and ETFs to be able to compare YTD returns.
|